Follow-The-Filings

Security

Acumen Pharmaceuticals Inc. · COM

Equity holders as of 2026 Q1 (each manager’s latest book)

6 owners 1 exit max 0.0% (Vanguard Group Inc.)

owners 6
max % 0.0%
tracked value $7M
qoq A 5 E 1

holders

sorted by % of portfolio · long equity only · exits show last held size

manager % port activity shares value history
Vanguard Group Inc. 2025 Q4 stale 0.0% Add 0.00 pp 1,653,772 $3M hist
Israel Englander - Millennium Management LLC 2026 Q1 0.0% Add 0.00 pp 659,675 $2M hist
Renaissance Technologies LLC 2026 Q1 0.0% Add 0.00 pp 473,946 $1M hist
Marshall Wace - Marshall Wace, LLP 2026 Q1 0.0% Add 0.00 pp 192,889 $455 hist
Two Sigma Investments, LP 2025 Q4 stale 0.0% Exit 0.00 pp 143,221 $302 hist
Steve Cohen - Point72 Asset Management, L.P. 2026 Q1 0.0% Add 0.00 pp 67,375 $159 hist
Ken Griffin - Citadel Advisors LLC exited 2026 Q1 last 2025 Q4 0.0% Exit 0.00 pp 345,283 $729 hist

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue
Gross profit
Gross margin
Net income -$52.37M -$102.33M -$121.34M
Net margin

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $246.62M $178.31M $122.25M
Total non-current assets * $63.51M $60.69M $581,000
Total assets $310.12M $238.99M $122.83M
Total current liabilities $12.97M $27.61M $30.01M
Total non-current liabilities * $30.18M $29.57M $22.4M
Total equity $266.97M $181.82M $70.43M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$43.06M -$86.22M -$115.54M
Cash from investing -$171.67M $48.03M $133.93M
Cash from financing $151.75M $6.93M -$34,000
Net change in cash * -$62.98M -$31.26M $18.36M

ownership over time

filing count by report period · click a bar for that quarter’s holders